Perrigo | PRGO - Gross Profit On Sales


Perrigo reported $313.9M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
AbbVie USD 14.39B 1.85B Jun/2026
Abbott USD 6.65B 787M Jun/2026
Bayer EUR 8.17B 1.24B Mar/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Coherus Biosciences USD 8.7M 853K Dec/2025
Corcept Therapeutics USD 252.09M 90.07M Jun/2026
Dr.Reddys Laboratories INR 41.78B 4.02B Jun/2026
Eli Lilly USD 16.22B 301.7M Mar/2026
J&J USD 18.55B 1.31B Jun/2026
Merck USD 12.09B 1.24B Mar/2026
Nestle CHF 19.99B 1.44B Jun/2026
Pacira USD 133.91M 7.27M Jun/2026
Perrigo USD 313.9M 11.6M Jun/2026
Pfizer USD -248M 11.29B Jun/2026
Phibro Animal Health USD 133.5M 12.6M Dec/2025
Prestige Brands USD 136.19M 10.11M Jun/2026
Reckitt Benckiser GBP 4.25B 2.08B Dec/2024
Sanofi EUR 8.71B 602M Jun/2026
Supernus Pharmaceuticals USD 160.06M 30.7M Jun/2026
Teva Pharmaceutical Industries USD 2.15B 45M Jun/2026
Xeris Pharmaceuticals USD 72.55M 404K Mar/2026
Zoetis USD 1.76B 140M Jun/2026